Published in Cancer Weekly, September 10th, 2002
In earlier studies, Dawn A. Kirschmann and colleagues at the Holden Comprehensive Cancer Center at The University of Iowa in Iowa City found that lysyl oxidase (LOX) expression, responsible for degrading the "glue" that holds cells together, is higher in breast cancers that are invasive than in breast cancers that are not.
A subsequent study has examined LOX at a molecular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.